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Abstract
Background: The Drosophila ovary is a tissue rich in post-transcriptional regulation of gene expression. Many of the regulatory
factors are proteins identified via genetic screens. The more recent discovery of microRNAs, which in other animals and tissues
appear to regulate translation of a large fraction of all mRNAs, raised the possibility that they too might act during oogenesis.
However, there has been no direct demonstration of microRNA-dependent translational repression in the ovary.
Methodology/Principal Findings: Here, quantitative analyses of transcript and protein levels of transgenes with or without
synthetic miR-312 binding sites show that the binding sites do confer translational repression. This effect is dependent on
the ability of the cells to produce microRNAs. By comparison with microRNA-dependent translational repression in other cell
types, the regulated mRNAs and the protein factors that mediate repression were expected to be enriched in sponge
bodies, subcellular structures with extensive similarities to the P bodies found in other cells. However, no such enrichment
was observed.
Conclusions/Significance: Our results reveal the variety of post-transcriptional regulatory mechanisms that operate in the
Drosophila ovary, and have implications for the mechanisms of miRNA-dependent translational control used in the ovary.
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Introduction
Small regulatory RNAs act in a wide range of processes that
contribute to control of gene expression. In eukaryotes, three classes
of such RNAs have been characterized most extensively. Small
interfering RNAs (siRNAs) mediate RNA interference or silencing,
in which target mRNAs are degraded. microRNAs (miRNAs) are
identical in structure to siRNAs, but have different origins and
processing. miRNAs regulate protein accumulation from target
mRNAs by a variety of mechanisms. Repeat associated small
interfering RNAs (rasiRNAs) are synthesized through yet another
pathway, and function in both chromatin organization and mRNA
degradation. Each class of small RNA acts in conjunction with a
protein complex consisting of an Argonaute family member and
associated proteins: the RNA provides specificity through base
pairing, either complete or incomplete, with targets, and the
proteins act as effectors by various mechanisms that in most cases
are not yet fully understood [1].
Oogenesis in Drosophila is a developmental context rich in post-
transcriptional control of gene expression [2]. Not surprisingly,
small RNAs are active in this setting. The most extensive evidence
is available for the rasiRNA pathway, for which the Argonaute
proteins are Piwi, Aubergine (Aub) and AGO3. The Piwi and Aub
proteins have well established roles during oogenesis in controlling
stem cell divisions and in the events leading to formation of the
embryonic germ line cells, but the details of their modes of action
were not well understood [3–5]. More recently, Piwi, Aub and
AGO3 have been found to associate with rasiRNAs, and piwi and
aub mutants (no AGO3 mutants have been described) are defective
in the rasiRNA dependent silencing of various retrotransposons
[6–10]. A number of genes have been implicated in the production
of rasiRNAs; mutation of any of these genes results in deregulation
of the transposons [7,11,12].
siRNAs were the first small regulatory RNAs shown to be active
during oogenesis, but with limitations on when they can function.
Late stage oocytes do not support RNA interference. However,
this pathway is activated during egg activation, and introduction of
exogenous dsRNAs results in degradation of target mRNAs [13].
Early in oogenesis the RNA interference pathway alters expression
of oskar (osk) mRNA, apparently via indirect effects on the
cytoskeleton [14]. It is not known why this pathway is not active
throughout all of oogenesis. AGO2, the Argonaute protein that
acts in RISC, the RNP complex that mediates RNA interference
[15], is present for all the stages of oogenesis when immunodetec-
tion is possible (i.e., prior to deposition of the vitelline membrane),
but whether it is present in the late stage oocytes that do not
support RNA interference is unknown [9,16].
Indirect evidence suggests that there will be miRNA-dependent
control of translation in the ovary. Multiple miRNAs are present
at high levels in early stage embryos, when zygotic transcription
has not yet begun, and so these should have been provided
maternally as a consequence of synthesis in the ovary [17].
Furthermore, several miRNAs have been directly shown to be
present in the ovary [6]. A second line of indirect evidence comes
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protein that acts in the miRNP, the RNP complex that mediates
miRNA-dependent translational control [15]. Mutation and
overexpression of AGO1 each affect, with opposite consequences,
the fate of germline stem cells, leading to the proposal that the
miRNA pathway acts in this process [18]. However, the roles of
different AGO proteins can overlap [19]. The roles of AGO1 and
AGO2 were defined in cultured Drosophila S2 cells [15], and
evidence that a particular protein has one role in one tissue does
not necessarily mean that it will do the same in all other settings.
The possibility of miRNA control in the germ line cells of the
ovary was also raised by a peculiar feature of osk mRNA
regulation. Specifically, in certain mutants with drastically reduced
levels of Osk protein, a large fraction of osk mRNA is present in
polysomes [20]. Such a phenomenon – polysome association of
mRNAs not directing the accumulation of the encoded protein – is
a feature of some mRNAs under miRNA control [1], although
other regulatory pathways have the same effect [21].
If miRNA-dependent translational control does operate in the
ovary, then the site or sites at which the regulation occurs will be of
interest, and may provide information about possible mechanisms.
At present, the mechanism of miRNA-dependent translational
repression is a subject of controversy. Some studies have pointed to
miRNAs intervening after the initiation of translation, which, as
noted above, results in association with polysomes without protein
accumulation [22–25]. Other analyses have revealed an effect of
miRNAs on initiation of translation [26–29]. The latter option fits
well with observed sites of miRNA regulation, in P bodies. P
bodies were initially identified, in yeast, as RNPs containing
mRNAs destined for degradation [30,31]. More recently,
mammalian P bodies have been found to contain mRNAs under
miRNA control, as well as AGO proteins and other proteins
required for the action of miRNAs [26,32,33]. Furthermore, in
cultured Drosophila cells P body formation has been shown to be a
consequence of RNA-mediated gene silencing, whether by AGO1-
or AGO2-dependent pathways [34]. P bodies lack ribosomes [31],
and so an mRNA under miRNA repression could not be in P
bodies if it is associated with polysomes. In the germline cells of the
Drosophila ovary there appear to be no conventional P bodies, but
instead a higher order structure known as sponge bodies. Sponge
bodies were first described as cytoplasmic sites at which the
Exuperantia (Exu) protein, which acts in mRNA localization, is
highly concentrated [35]. Subsequently, a number of other
proteins with roles in post-transcriptional control of gene
expression have been shown to colocalize with Exu [36–42].
Notably, the sponge body proteins include homologs of multiple P
body components, and sponge bodies are largely devoid of
ribosomes [35]. Sponge bodies and P bodies do not appear to be
equivalent, as sponge bodies include cisternae and vesicles while
no membrane is found in the P body-like GW182 bodies (there
have been no ultrastructural studies of P bodies)[35,43]. However,
it does seem likely that sponge bodies represent a membrane-based
framework upon which RNPs similar or equivalent to P bodies are
positioned. By analogy to mammalian cells and to cultured
Drosophila cells, these sponge body RNPs would be an expected site
of miRNA action.
Here we directly test for miRNA-dependent translational
repression in the ovary, and find that it does occur. We also show
that there is no detectable concentration of repressed mRNAs with
sponge bodies. Instead, the regulated mRNAs are present in
numerous very small cytoplasmic particles. Both AGO1 and
AGO2 (or GFP fusions to these proteins) appear in similar small
particles. These results do not rule out any specific model for the
mechanism by which miRNAs repress translation in the ovary, but
do allow for translational inhibitory mechanisms that act after
initiation of translation.
Results
To test for miRNA activity in the Drosophila ovary we focused on
miR-312. Northern blot analysis of miRNAs during embryogenesis
has revealed that miR-312 is present at the highest levels in 0–
1 hour embryos, suggesting that it is expressed during oogenesis
[17]. Indeed, miR-312 expression in the ovary has been detected
by a PCR assay [44]. We confirmed the ovarian expression of miR-
312 by in situ hybridization. A Locked Nucleic Acid probe for
miR-312 reveals the miRNA to be present throughout the ovary, in
both germ line cells (nurse cells and the oocyte) and somatic follicle
cells (Fig. 1A). By contrast, a probe with a scrambled sequence
shows no hybridization (Fig. 1B).
To monitor potential miR-312 repressive activity, a GFP
reporter assay was developed. Six tandem copies of a synthetic
miR-312 binding site were added to the 39 UTR of a UAS-GFP
transgene (Fig. 1C). The binding sites were designed to allow
incomplete base pairing with miR-312, such that the 59 ‘seed’ and
39 regions of the miRNA would be fully base paired, with a central
unpaired bulge (Fig. 1D). Interrupted base pairing of this type
usually leads to translational repression by miRNAs, rather than
RNA degradation [45–47]. Multiple copies of the miR-312 binding
sites were used to increase the probability of efficient miR-312
binding. Although no confirmed targets of miR-312 action have
been identified, the ovarian kelch mRNA is a candidate with 4
predicted miR-312 binding sites [48]. Transcription of the reporter
transgene relies on the UAS component, which responds to the
GAL4 transcriptional activator [49,50]. Following expression of
the reporter (UAS-GFP-312) and control (UAS-GFP) transgenes in
the germline cells of the ovary using the matalpha4-GAL-VP16
driver, GFP protein and mRNA levels were measured by
quantitative western blot analysis and quantitative real time
PCR (RT-PCR). The transgene with miR-312 sites produces
significantly less GFP than the control transgene (Fig. 1E). This
difference can be attributed in part, but not in whole, to unequal
mRNA levels: the mRNA with miR-312 targets is present at 70%
of the level of the control transgene (Fig. 1E). Normalization for
the different mRNA levels reveals that the GFP -312 mRNA is
about half as active as the control GFP mRNA in production of
GFP protein (Fig. 1E). Thus, the presence of the miR-312 target
sites in the GFP-312 mRNA confers translational repression.
As an additional assay of miRNA activity, a second set of
transgenes was constructed and tested. The UAS-osk control
transgene is similar to UAS-GFP, except that the coding region is
now from an osk cDNA (with none of the osk 39 UTR). UAS-osk-
312 differs from UAS-osk by the addition of four tandem copies of
the synthetic miR-312 binding site. When expressed in the ovary
using the matalpha4-GAL-VP16 driver, the UAS-osk control
transgene produces ectopic Osk, which disrupts anterior embry-
onic body patterning resulting in a very high frequency of bicaudal
embryos (96%; n=131)(Fig. 1F). In contrast, expression of the
UAS-osk-312 transgene with the miR-312 binding sites has no
significant effect on embryonic patterning: the vast majority of
embryos (94%; n=373) appear wild type (Fig. 1G). Both transgene
mRNAs are present at similar levels (Fig. 1H). Thus, in each of two
assays the addition of miR-312 binding sites to an mRNA leads to
its translational repression.
Translational repression of the reporter mRNAs could be due to
the action of miRNAs, or could arise in some other manner
because of the addition to the reporter mRNA of the sequences
that make up the miR-312 binding sites. To distinguish between
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PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4669miRNA Action in Oogenesis
PLoS ONE | www.plosone.org 3 March 2009 | Volume 4 | Issue 3 | e4669these options we asked if miRNAs are required for the observed
repression of the GFP reporter mRNA. Loquacious (Loqs) protein
acts in processing pre-miRNAs, and loqs mutants are defective in
this process [51]. In loqs mutant ovaries the level of GFP produced
from the UAS-GFP-312 transgene was elevated about 26relative
to loqs/+ heterozygotes, while mRNA levels did not show a
corresponding increase (Fig. 2A). This change in protein level
corresponds well to the observed level of translational repression,
and demonstrates that repression is dependent on miRNAs.
GFP levels in individual egg chambers were also examined by
confocal microscopy. Comparison of ovaries expressing either the
GFP or GFP-312 mRNAs reveals two differences. First, the overall
GFP level was typically lower from the mRNA with the miR-312
targets, consistent with the quantitative western blot analysis.
Second, GFP levels dropped at later stages for the GFP-312
mRNA, but not for the GFP mRNA (Fig. 2B,C). To quantify this
effect GFP levels were measured at different stages of oogenesis
within individual ovarioles: at stage 7/8 (before the reduction) and
at stage 10. Of the ovarioles expressing GFP-312 mRNA, greater
than 75% showed at least a 1.5 fold reduction in GFP at the later
stage, while less than 5% of ovarioles expressing GFP mRNA
showed such a reduction (Fig. 2D).
Although the quantitative measures of mRNA and protein levels
for the reporter transgenes clearly demonstrate an effect at the
level of protein accumulation, it remains possible that miR-312 is
also affecting the stability of the reporter mRNA. Because the
reporter and control mRNAs are expressed from different
transgenes, the site of transgene insertion might influence
transcription (transgenes under UAS/GAL4 control do show
some line-to-line variability in expression levels). Thus we cannot
readily determine if the differences in levels for the GFP-312 and
GFP mRNAs are due to the action of miRNAs. However, it is
simple to determine if the late stage reduction in GFP translated
from the GFP-312 mRNA is accompanied by a reduction in
transcript levels. For both GFP and GFP-312 mRNAs there is a
substantial increase in mRNA levels later in oogenesis, rather than
a decrease (Fig. 2E,F), consistent with the known activity of the
GAL4 driver used for expression [52]. Why the GFP-312 mRNA is
more effectively repressed at later stages of oogenesis is uncertain.
The levels of miR-312 RNA appear to increase during this period
(Fig. 1A), but attempts to use fluorescent-based in situ hybridiza-
tion to obtain more quantitative data that would address this
possibility have not been successful.
Sites of miRNA activity in the ovary
Having demonstrated that miRNA-dependent translational
repression does occur in the ovary, we wished to ask if the
repressed mRNAs and factors involved in repression are
concentrated in sponge bodies.
In one line of experiments the distributions of Argonaute family
members were monitored, either by live imaging of GFP fusion
proteins or by immunodetection in fixed samples. For live imaging
a Me31B::GFP fusion protein was used to mark sponge bodies,
and AGO1::GFP and AGO2::GFP distributions were evaluated.
In other tissues AGO1 is primarily responsible for miRNA-
mediated translational repression, while AGO2 acts in RNA
interference [15]. In the ovary both AGO proteins are
predominantly cytoplasmic, with much lower levels in the nuclei.
This pattern is strikingly distinct from the characteristic sponge
body distribution seen with the Me31B::GFP marker. Sponge
bodies are also cytoplasmic, but are concentrated in discrete large
domains (Fig. 3A).
At higher magnification, the distribution of both AGO1::GFP
and AGO2::GFP can be seen to be punctate, with the proteins
appearing in many small foci (Fig. 3B,C). This distribution is not
characteristic of GFP fusion proteins [53]. Moreover, the
distribution is distinctly different from that of GFP alone, which
is more uniform in the cytoplasm (Fig. 3D). As a quantitative
measure of the difference between the patterns of GFP and the
AGO::GFP fusion protein distributions, we evaluated the range of
fluorescence intensities. A uniform protein distribution in a given
field should show a narrow range of fluorescence intensity. In
contrast, a protein that is concentrated in particles should show a
broader range of intensities: low outside of the particles, and high
in the particles. Fluorescence intensities were assigned colors in a
look up table (LUT)(see Fig. 3 legend). The variation in
fluorescence intensity is much greater for AGO1::GFP and
AGO2::GFP than for GFP (Fig. 3B’–C’). This variation confirms
that both AGO fusion proteins are concentrated at many small
foci. In a direct comparison of protein distributions by immuno-
staining of fixed egg chambers, AGO1 was detected in tiny foci
similar in number and distribution to those detected with
AGO1::GFP in live samples (Fig. 3E), while Bruno (Bru; a sponge
body component; [54,55]) was largely non-overlapping and
predominantly in the much larger sponge bodies (Fig. 3F,G).
Similarly, the Drosophila ortholog of Dcp1, a component of P
bodies in other organisms [56,57] and of sponge bodies in the
Drosophila ovary [41], was found in sponge bodies but not in the
AGO1-positive puncta (Fig. 3I,J).
Knowledge of the AGO protein distribution in the egg chamber
provides useful but nevertheless limited information about the sites
of miRNA mediated repression. The absence of any enrichment of
AGO1 and AGO2 proteins (or GFP fusions of these proteins) in
sponge bodies suggests that sponge bodies are not the primary
destination for mRNAs under miRNA control. The many small foci
of AGO proteins in the cytoplasm are good candidates for sites of
repression. However, it is also possible that the lower level of more
uniformly distributed AGO proteins comprise the fraction actively
Figure 1. Expression and activity of miR-312 in the ovary. A and B. In situ hybridization with locked nucleic acid probes. The probe in A is
complementary to miR-312, while the probe in B has a scrambled sequence. The miR-312 hybridization signal appears throughout these stages of
oogenesis (levels are very low at the earliest stages of oogenesis, at the extreme left. C. GFP reporter transgenes to detect miR-312 activity. The
diagrams show the transgene mRNAs (not to scale). Transgenes with the osk coding region as the reporter are essentially the same, with replacement
of the coding regions, except that the GFP reporter has 6 copies of the miR-312 binding site while the osk reporter has 4 copies. D. Sequence of a
single copy of the miR-312 synthetic binding site, shown as it would base pair to miR-312. E. Translational repression of the UAS-GFP-312 reporter
transgene. GFP protein and mRNA levels were measured by quantitative western blotting and quantitative real time PCR, respectively, with levels
from the UAS-GFP transgene normalized to 1. Averages from 3 or more experiments are shown, with standard deviations indicated. Normalization for
mRNA levels, at right, reveals the level of translational repression per unit of mRNA. Note that the regulated and unregulated mRNAs are expressed
from different transgenes and that any effect of the miR-312 binding sites on mRNA levels can not be addressed in this analysis. If the presence of the
miR-312 binding sites reduces mRNA levels, as is common in cases of miRNA regulation, then the effective degree of negative regulation would be
even greater. F. Wild type cuticle of an embryo from females expressing UAS-osk-312. G. Bicaudal cuticle of an embryo from females expressing UAS-
osk. H. Levels of mRNA from osk reporter transgenes, measured by quantitative real time PCR and normalized to 1 for the unregulated UAS-osk
transgene mRNA. Averages from 3 or more experiments are shown, with standard deviations indicated.
doi:10.1371/journal.pone.0004669.g001
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directly monitor sites of miRNA action in the ovary.
Using a tethering assay, control mRNAs and mRNAs under
miRNA repression were tracked in live samples. In this type of
assay, a fusion protein consisting of an RNA binding domain and
GFP is tethered to an mRNA bearing the appropriate RNA
binding sites [58]. We used an MS2 coat protein::GFP
(MCP::GFP) fusion protein previously shown to work in this assay
in Drosophila egg chambers [59], together with UAS-osk reporters as
described above (the UAS-GFP type of reporter transgene could
not be used, as expression of GFP from the reporter would create a
high background that would interfere with specific detection of the
tethered MCP::GFP). In the absence of any transcripts with the
MS2 binding sites, the MCP::GFP protein is largely nuclear
(Fig. 4A) as it contains a nuclear localization signal (NLS).
However, when reporter transcripts with MCP binding sites (with
or without miR-312 target sites) are also present, the MCP::GFP
adopts a new distribution: it is now predominantly cytoplasmic
(Fig. 4B,C). The shift to the cytoplasm presumably results from
nuclear export of reporter mRNAs. Bound molecules of
MCP::GFP are thus moved into the cytoplasm, reducing the
fraction of MCP::GFP in the nuclei. The UAS/GAL4 expression
system allows for high levels of transcription, and it is therefore not
surprising that the reporter transcripts can influence the balance of
MCP::GFP between the nucleus and cytoplasm.
Within the cytoplasm the tethered reporter mRNAs, both
regulated and unregulated, are present in very small particles
distributed in very similar patterns (Fig. 4A,B). In contrast,
MCP::GFP in the absence of reporter transcripts is more evenly
distributed (Fig. 4A). The reporter transcripts do not appear in
Figure 2. Translational repression of GFP-312 mRNA requires miRNA production. A. Quantitation of protein and mRNA levels from the UAS-
GFP-312 transgene in females heterozygous or homozygous for loqs
f00791. Levels were determined as in Figure 1. B and C. GFP in ovarioles expressing
the UAS-GFP (B) or UAS-GFP-312 (C) transgenes. GFP is in green, and phalloidin staining in red. GFP signal intensity at early stages of oogenesis (to the
left in the panels) is typically lower for the UAS-GFP-312 transgene, but was adjusted to show a similar intensity as for UAS-GFP at those stages; this
better reveals the extent of the difference between GFP levels for the two transgenes at later stages of oogenesis (at right). D. Quantitation of early/
late stage GFP levels in individual ovarioles. Fluorescence intensity was measured in stage 7 or 8 and 10 egg chambers of individual ovarioles. If the
ratio of fluorescence in stage 7/8 to stage 10 was greater than 1.5, then the ovariole was considered to show repression. E and F. In situ hybridization
detection of GFP (E) and GFP-312 (F) mRNAs.
doi:10.1371/journal.pone.0004669.g002
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enriched in sponge bodies. As a more direct demonstration of this
property, the sponge body component Bru was detected
simultaneously with MCP::GFP in fixed samples of these ovaries.
No concentration of the tethered reporter mRNAs in the Bru-
containing sponge bodies was detected (Fig. 4D).
The patterns in which AGO proteins and regulated and
unregulated reporter transcripts are distributed are indistinguish-
able. This similarity could simply indicate that each molecule is
found in many small RNP particles that are dispersed throughout
the cytoplasm. If the foci of transcripts under miRNA regulation
do correspond to sites of repression, then they might be expected
to be coincident with the foci of AGO1 protein. We tested this
prediction by double labeling. Notably, there is very little overlap
in the two types of foci (Fig. 4E).
Discussion
Evidence presented here addresses the possibility that miRNA
dependent control of gene expression occurs in the Drosophila ovary.
The miRNA miR-312 is expressed during oogenesis, and addition of
synthetic miR-312 binding sites to either of two different reporter
mRNAsreducestheiractivities.Thiseffectisdependentonthe ability
of the ovary to synthesize miRNAs. Collectively, these results make a
compelling case for activity of miRNAs in the ovary. Furthermore,
the data show that the stages when miRNA dependent regulation
occurs include the mid to late stages of oogenesis, when post-
transcriptional control of gene expression plays a crucial role in the
events that lead to patterning of the embryo. Thus, miRNAs have the
potential to contribute to this process.
Although we have focused only on a single miRNA, many of the
known miRNAs are present at high levels in early stage embryos
that have not initiated zygotic transcription [17], and these
miRNAs should also be present in the germ line cells of the ovary.
Our evidence shows that the miRNA machinery is competent for
function during oogenesis, and it would be very unlikely that only
miR-312 can make use of that machinery. Thus, there is every
expectation that in oogenesis numerous miRNAs are actively
Figure 3. Subcellular distribution of AGO and AGO::GFP
proteins in the ovary. Panels A–D show the distributions of GFP
fusion proteins in the nurse cells of live stage 9 egg chambers, with
higher magnification images in A’–D’. Scale bars are 10 mm in A–D and
5 mm in A’–D’. A, Me31B::GFP; B, AGO1::GFP; C, AGO2::GFP; and D, GFP.
The lower resolution images (with the nuclei marked as N) demonstrate
the absence of any detectable concentration of either of the AGO::GFP
fusion proteins in localized regions of the cytoplasm, as would be the
case if they are enriched in sponge bodies. Sponge body distribution is
shown by Me31B::GFP. The higher resolution images reveal that both
AGO::GFP fusion proteins are distributed in many small puncta that are
fairly evenly spread throughout the cytoplasm (examples of individual
puncta are indicated by arrows). By contrast, GFP alone (D’) is more
uniform and lacks puncta of the size seen for the fusion proteins. The
insets in B’–D’ are higher resolution images of the regions in B’–D’
indicated by arrows. The representation of each fluorescence value was
changed in ImageJ (NIH) from a black and white scale (look up table;
LUT) to the Union Jack LUT which represents the lowest fluorescence as
black and progressively higher fluorescence levels are blue, white, and
then red. AGO1::GFP and AGO2::GFP fluorescence is concentrated in
puncta (appearing white and red in the insets in B’,C’) that are not
observed for GFP (inset in D). Panels E–G show a portion of a nurse cell
of a fixed stage 9 egg chamber probed with antibodies to detect AGO1
(E) and Bru (F), or both (G; AGO1 in green, Bru in red). Panels H–I are
similar, with detection of AGO1 (H), dDcp1::YFP (I) or both (J; AGO1 in
green, dDCP1::YFP). The AGO1 distribution is particulate, just as for the
AGO1::GFP fusion protein, and shows no enrichment in sponge bodies,
for which Bru and dDcp1::YFP are markers ([41,55]). Scale bars are 5 mm.
doi:10.1371/journal.pone.0004669.g003
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miRNAs.
To address the question of where in the ovary miRNA-
mediated translational repression occurs, we monitored the
distribution of AGO proteins and reporter mRNAs under miRNA
control. Using high resolution confocal microscopy and detection
either by immunofluorescence in fixed ovaries or live imaging of
an AGO1::GFP fusion, we find that AGO1 is present in many
small foci rather than being uniformly dispersed throughout the
cytoplasm. A similar pattern is observed for reporter mRNAs
detected by indirect labeling with tethered GFP, independent of
whether they are under miRNA control. The AGO1-containing
foci are distinct from those containing the regulated reporter
mRNAs. Thus, the significance of the small foci remains
uncertain.
The main conclusion of this portion of our work is that sponge
bodies are not the primary sites of miRNA activity. Notably,
neither AGO1 nor the repressed mRNAs display any detectable
concentration in sponge bodies (see also [16]). Sponge bodies are
similar to P bodies, with many shared components [36–42]. In
some other cell types P bodies are enriched in miRNP
components, and can readily be seen as bright foci on a darker
background when either miRNP protein components or regulated
mRNAs are detected with fluorescent labels [26,33,60]. This
enrichment initially suggested that a major fraction of the miRNP
components are in P bodies. However, subsequent quantitative
analyses revealed that only a very small fraction (less than 2%) of
the miRNP AGO protein is in the P bodies, and that the vast
majority of the protein is in the cytoplasm but diffuse and therefore
more difficult to detect [61]. By way of comparison, then, our
failure to detect any enrichment of AGO1 or transcripts under
miRNA control in sponge bodies indicates that the fraction
present must be substantially less than the 2% of the cited
example; in effect, there can be essentially no enrichment at all.
The distribution of miRNPs within the cell is relevant to the
mechanism by which translation is repressed by miRNAs. P bodies
lack ribosomes, and the presence of certain miRNPs and their
regulated mRNAs within P bodies indicates that these mRNAs are
not undergoing translation. This fits well with some models for
miRNA-dependent repression, in which the initiation of transla-
tion is inhibited [26–29]. There is also evidence for regulation by
miRNAs after initiation of translation, with the repressed mRNAs
being associated with polysomes [22–25]. Obviously, such a
mechanism could not apply for the mRNAs found in P bodies.
Consequently, any enrichment of miRNPs in sponge bodies
(whose similarity with P bodies includes an almost complete lack of
ribosomes [35]), would be consistent with repression blocking
initiation of translation. The observed absence of such an
enrichment raises the possibility that whatever mechanism delivers
miRNPs to the P bodies is not operating in the germline cells of the
ovary (where the sponge bodies are found), at least for the
developmental stages examined. While this does not rule out
miRNA-dependent translational repression at the level of
initiation, it does leave open the possibility that action of miRNAs
after initiation of translation may be more prominent in this setting
than in cells with conventional P bodies.
Materials and Methods
Plasmids
UAS-GFP (p8508) is pUASp [50] to which mGFP6 [61] has been
introduced as an Asp718 fragment into the Asp718 site. The
mGFP6 Asp718 fragment begins with GGTACCCAATTCGT-
TAACAGATCCAAGGAGATATAACA prior to the mGFP6
Figure 4. Sites of miRNA action in the ovary. Panels A–C show the
distribution of MCP::GFP in nurse cells of live stage 10A egg chambers,
with higher magnification images of cytoplasmic regions in A’–C’. Scale
bars are 10 mm in A–C and 5 mm in A’–C’. A–C differ with respect to
which reporter mRNAs with MS2 binding sites are present: A, no
reporter mRNAs; B, reporter mRNAs lacking miR-312 binding sites; and
C, reporter mRNAs with miR-312 binding sites. The cytoplasmic
MCP::GFP distributions were the same at earlier stages of oogenesis.
Note that the size of the particles is similar to those marked with the
AGO::GFP fusion proteins in Fig. 3, but the number of particles seen in
each field is lower. The insets in A’–C’ are a higher resolution image of
the regions in A’–C’ indicated by arrows, with Union Jack LUTs as
described in the legend to Fig. 3. MS2::GFP in the presence of the osk
reporter mRNAs, with or without miR-312 binding sites, is cosncentrated
in puncta (appearing white and red in the insets in B’,C’) that are not
observed with MS2::GFP alone (inset in A’). Panels D and E show the
distribution of MCP::GFP (green in D and E) tethered to the osk-312
reporter transcripts, and either sponge bodies (revealed by anti-Bru; red
in D) or AGO1 puncta (red in E). The sponge bodies and AGO1 puncta
(arrows in D and E) do not colocalize with the tethered reporter
transcripts (arrowheads in D and E). Scale bars are 5 mm in D and E.
doi:10.1371/journal.pone.0004669.g004
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stop codon. A synthetic single miR-312 binding site cassette was
constructed by PCR and had the sequence 59TCTAGAT-
CAGGCCGTAGAAGTGCAATACTAGT 39. This cassette,
which includes XbaI and SpeI sites at the 59 and 39 ends, was
multimerized using the XbaI and SpeI sites. A 66 version was
inserted into the XbaI site of UAS-GFP to make UASp-GFP-312
(p8701). A 46version of the miR-312 binding sites was introduced
into the XbaI site between the osk coding region and UASp vector
39 UTR of UAS-osk [62] to make UAS-osk-312 (p8619). UAS-osk-
312 was further modified by addition of 16 copies of the MS2 coat
protein binding site to the 39 UTR [57] to make UAS-osk-312-MS2
(p8492). UAS-osk was modified in the same manner to make UAS-
osk-MS2 (p8516).
Fly strains
loqs
f00791 flies were from Bill Theurkauf. Transgenes constructed
in this study were injected by Genetic Services, Inc. GFP trap
stocks were the following: AGO1
CA06914; AGO2
CA07002; and
ME31B::GFP
ZCL1796 [53,64]. The latter GFP trap was recovered
from stock ZCL1796, which was described as having an insertion
that tags CG3634 on the third chromosome. Molecular charac-
terization of this stock revealed that the GFP fluorescence from
this line was entirely from a second GFP trap insertion in the
me31B gene. MS2::GFP was from E. Gavis. The expression of UAS
transgenes was driven by the matalpha4-GAL-VP16 driver [52].
YFP::dDcp1 was from Tze-Bin Chou [41].
Real-time RT PCR
RNA was isolated from dissected ovaries using Tri Reagent-LS
according to the manufacturers instructions (Molecular Research
Center). 2 mg of ovarian RNA was reverse transcribed using random
primers and the High Capacity cDNA Reverse Transcription kit
(Applied Biosystems). Real-time PCR was performed using the
7900HT Sequence Detector and the Power SYBR Green PCR
Master Mix (Applied Biosystems). mRNA levels were determined by
relative quantitation with a standard curve and normalized to RpL32
mRNA. All experiments were performed at least 3 times. Primers to
amplify cDNAs were the following: GFP, TTTTCGTT-
GGGATCTTTCGAA and ACGGCGGCGTGCAAC; RpL32,
GCGCACCAAGCACTTCATC and GACGCACTCTGTT-
GTCGATACC; osk, GCGTTAGGTCCTGTTCATTGGT and
GCCATCGCTTGGAGGAAAG.
Quantitative western analysis
Ovaries were collected on ice and homogenized in SDS-PAGE
loading buffer with protease inhibitors (5 mM benzamidine and
10 mM PMSF). Samples were boiled for 5 minutes and loaded on
a SDS-PAGE gel. Western blots were performed using the LI-
COR detection system according to the manufacturers instruc-
tions and imaged using a Odyssey Infrared Imaging System (LI-
COR Biosciences). GFP protein levels were normalized relative to
ß-tubulin. All experiments were performed at least 3 times. Anti-
GFP antibodies were prepared by Josman Laboratories. ß-tubulin
was detected with monoclonal antibody E7 from the Develop-
mental Studies Hybridoma Bank.
In-situ hybridization
To detect miR-312, a digoxigenin labeled Locked Nucleic Acid
probe (TATTGCACTTGAGACGGCCTGA)(Exiqon) was used
according to the manufacturers instructions with annealing
temperature of 55uC. The sequence of the scrambled control
probe is TTCACAATGCGTTATCGGATGT. To detect GFP
mRNA, an antisense probe was prepared by in vitro transcription
and labeled with digoxigenin. Hybridization and detection were
performed as described [64] except that the first wash following
hybridization was raised 3 degrees C (relative to the hybridization
temperature) to reduce background.
Immunofluorescence and microscopy
Ovaries were fixed, stained and imaged as described [63],
except for the analysis of Fig. 2, in which ovaries were fixed as
described [4] and stained with AlexaFluor 594 phalloidin
(Molecular Probes). The area based analysis function of the Leica
Confocal Software was used to measure the mean GFP
fluorescence in the nurse cell cytoplasm. Fluorescence in regions
of the same size was measured in three nurse cells from each egg
chamber. Antibodies were used at the following dilutions: rabbit
anti-AGO1 ab5070 (Abcam), 1/100; rat anti-Bru, 1/500. Live
imaging of GFP was performed as described previously [63].
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